Skip to main content
. Author manuscript; available in PMC: 2015 Jun 9.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Nov 15;5(2):283–289. doi: 10.1158/1940-6207.CAPR-11-0257

Figure 5.

Figure 5

Multiplicity by lesion type in animals receiving 40mM NTCU based on the development of SCC. The number of high-grade dysplasia lesions present in animals with SCC is significantly higher than in animals with no SCC. *p<0.05